Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAPNA BHATIA

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1619139813
CMS profile
380659
Location
HENDERSON, NV

General Payments · PY2018–2024

$9,788.97

  • Reported across 227 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$780.56

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $780.56 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $332.69 4
PY2019 $875.77 6
PY2020 $82.97 4
PY2021 $964.30 10
PY2022 $3,462.38 76
PY2023 $3,290.30 89
PY2024 $780.56 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $27.72 01/09/2024 Food and Beverage Undisputed 01/23/2026 1078902247 CMS
Actelion Pharmaceuticals US, Inc. $24.56 02/14/2024 Food and Beverage Undisputed 01/23/2026 1078902183 CMS
Actelion Pharmaceuticals US, Inc. $26.18 04/19/2024 Food and Beverage Undisputed 01/23/2026 1078902119 CMS
Actelion Pharmaceuticals US, Inc. $29.15 05/31/2024 Food and Beverage Undisputed 01/23/2026 1078902235 CMS
Amgen Inc. $15.67 01/23/2024 Food and Beverage Undisputed 01/23/2026 1115450443 CMS
Amgen Inc. $16.30 03/05/2024 Food and Beverage Undisputed 01/23/2026 1115450447 CMS
Amgen Inc. $11.60 04/04/2024 Food and Beverage Undisputed 01/23/2026 1115450452 CMS
Amgen Inc. $6.90 04/18/2024 Food and Beverage Undisputed 01/23/2026 1115450457 CMS
Amgen Inc. $27.49 05/08/2024 Food and Beverage Undisputed 01/23/2026 1115450461 CMS
Amgen Inc. $8.63 06/07/2024 Food and Beverage Undisputed 01/23/2026 1115450465 CMS
Amgen Inc. $5.24 06/26/2024 Food and Beverage Undisputed 01/23/2026 1115450468 CMS
Amgen Inc. $7.78 07/10/2024 Food and Beverage Undisputed 01/23/2026 1115450471 CMS
Amgen Inc. $8.02 07/22/2024 Food and Beverage Undisputed 01/23/2026 1115450476 CMS
Amgen Inc. $9.70 08/22/2024 Food and Beverage Undisputed 01/23/2026 1115450480 CMS
Amgen Inc. $5.74 10/03/2024 Food and Beverage Undisputed 01/23/2026 1115450484 CMS
Amgen Inc. $9.10 10/18/2024 Food and Beverage Undisputed 01/23/2026 1115450488 CMS
Amgen Inc. $10.56 11/12/2024 Food and Beverage Undisputed 01/23/2026 1115450492 CMS
Amgen Inc. $8.14 12/03/2024 Food and Beverage Undisputed 01/23/2026 1115450496 CMS
Amgen Inc. $10.18 12/13/2024 Food and Beverage Undisputed 01/23/2026 1115450502 CMS
AstraZeneca Pharmaceuticals LP $60.06 01/29/2024 Food and Beverage Undisputed 01/23/2026 1104647313 CMS
AstraZeneca Pharmaceuticals LP $80.11 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104314968 CMS
AstraZeneca Pharmaceuticals LP $20.07 02/29/2024 Food and Beverage Undisputed 01/23/2026 1105424128 CMS
AstraZeneca Pharmaceuticals LP $59.86 04/26/2024 Food and Beverage Undisputed 01/23/2026 1104248985 CMS
AstraZeneca Pharmaceuticals LP $20.92 09/25/2024 Food and Beverage Undisputed 01/23/2026 1105522899 CMS
Axsome Therapeutics, Inc. $34.43 05/15/2024 Food and Beverage Undisputed 01/23/2026 1148318952 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.63 02/02/2024 Food and Beverage Undisputed 01/23/2026 1118080790 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.81 06/07/2024 Food and Beverage Undisputed 01/23/2026 1118080788 CMS
Electromed, Inc. $31.47 01/25/2024 Food and Beverage Undisputed 01/23/2026 1137880434 CMS
Electromed, Inc. $7.82 02/22/2024 Food and Beverage Undisputed 01/23/2026 1137880438 CMS
Electromed, Inc. $29.55 03/22/2024 Food and Beverage Undisputed 01/23/2026 1137880442 CMS
Electromed, Inc. $20.15 04/09/2024 Food and Beverage Undisputed 01/23/2026 1137880447 CMS
Electromed, Inc. $10.46 07/08/2024 Food and Beverage Undisputed 01/23/2026 1137880451 CMS
Electromed, Inc. $5.22 07/29/2024 Food and Beverage Undisputed 01/23/2026 1137880456 CMS
Electromed, Inc. $3.00 08/22/2024 Food and Beverage Undisputed 01/23/2026 1137880460 CMS
Electromed, Inc. $5.23 12/03/2024 Food and Beverage Undisputed 01/23/2026 1137880464 CMS
Electromed, Inc. $12.49 12/04/2024 Food and Beverage Undisputed 01/23/2026 1137880468 CMS
GlaxoSmithKline, LLC. $28.91 04/29/2024 Food and Beverage Undisputed 01/23/2026 1116493864 CMS
Regeneron Healthcare Solutions, Inc. $28.71 01/26/2024 Food and Beverage Undisputed 01/23/2026 1114010019 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.